Drugs, genes and screens: The ethics of preventing and treating spinal muscular atrophy
Spinal muscular atrophy (SMA) is the most common genetic disease that causes infant mortality. Its treatment and prevention represent the paradigmatic example of the ethical dilemmas of 21st-century medicine. New therapies (nusinersen and AVXS-101) hold the promise of being able to treat, but not cu...
| Authors: | ; ; |
|---|---|
| Format: | Electronic Article |
| Language: | English |
| Check availability: | HBZ Gateway |
| Journals Online & Print: | Drawer...
|
| Fernleihe: | Fernleihe für die Fachinformationsdienste |
| Published: |
Wiley-Blackwell
[2020]
|
| In: |
Bioethics
Year: 2020, Volume: 34, Issue: 5, Pages: 493-501 |
| IxTheo Classification: | NCH Medical ethics |
| Further subjects: | B
Ethics
B treatment versus prevention B pre-conception screening B spinal muscular atrophy B disability screening |
| Online Access: |
Presumably Free Access Volltext (Verlag) Volltext (doi) |